First treatment for late-stage dry AMD rejected by UK drug regulator
Leading sight loss charity the Macular Society has responded to the decision not to approve the first potential treatment for geographic atrophy (GA) or late stage dry aged-related macular degeneration. The decision is a significant setback for those affected by...
AOP welcomes focus on improved patient outcomes in Pharmacy Supervision Review Group report
Recommendations review legislative framework for the future delivery of pharmacy.
